Impaired Decision-Making And The Role Of Dopamine In Modulating Executive Function In Parkinson’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$390,468.00
Summary
Patients with Parkinson’s Disease (PD) often experience significant impairments in their ability to make decisions, even in the earliest stages of the disease. This project will use a combination of psychophysics, pharmacotherapy and functional neuroimaging to examine the decision-making impairments that occur in PD, and how they are modulated by dopamine. We anticipate our findings will lead to improvements in the diagnosis and management of the syndromes of executive dysfunction seen in PD.